4//SEC Filing
Edge Therapeutics, Inc. 4
Accession 0001127602-16-056139
$PDSBCIK 0001472091operating
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 9:53 AM ET
Size
4.8 KB
Accession
0001127602-16-056139
Insider Transaction Report
Form 4
Conti Kurt G
Director
Transactions
- Award
Stock Option (right To Purchase)
2016-06-21+15,000→ 15,000 totalExercise: $9.34From: 2017-06-21Exp: 2026-06-21→ Common Stock (15,000 underlying)
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001472091
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 9:53 AM ET
- Size
- 4.8 KB